CD8A and cancer: IgA+-producing plasma cells express inhibitory molecules such as PDL-1 and secrete IL-10, a potent anti-inflammatory cytokine that strongly inhibits cytotoxic CD8+ T cell function [128], thus impairing immune cancer surveillance in NASH-related HCC [86] (Figure 2).